The 2nd CRIG industrial partnering event connected over 180 delegates from industry and academia on innovations in cancer research

CRIG

On Friday 25th October 2019, CRIG successfully hosted its 2nd industrial partnering event in AuditoRium4 (Ghent). Over 90 delegates from 47 life science companies and 90 delegates from  academia discussed the latest innovations in cancer research, and networked towards creating new, synergic collaborations in oncology.

The event showcased expertise from CRIG and its partners, bringing together researchers, clinicians, pharma companies, SME and many others, all with the common goal to bring better and faster results to cancer patients.

Warming up at the breakfast tables, our delegates had in-depth brainstorming on innovations, bottlenecks, needs and advances in Immuno-oncology, Clinical Trials, and AI & Precision Medicine.

Pitches from both academia and CRIG forged the 8 sessions (Immuno-oncology, Novel cancer therapies, Precision oncology, Non-invasive diagnostics cancer modelling, AI, Digital Health and big data and New players in the Belgian ecosystems and spinoff projects) of the event, which welcomed 2 keynote speakers, dr. David Gilham (vice-president research & development, Celyad) and dr. Hans Hofstraat (vice-president Philips Research).

A speed dating round facilitated face-to-face networking and allowed delegates to connect.

Check here for the program of the event.

The event in numbers
180 delegates
54 different affiliations of which 47 companies
60 CRIG members (clinicians, profs and postdoc level)
21  sponsors
2 keynote presentations
8 sessions
46 pitches presented
3 breakfast table discussions


Help us improve!

Your feedback matters: please fill in the online feedback form to help us improving and giving you the best networking experience.

 

Innovate with us!

Get in touch with the CRIG business unit:

CRIG Central point of contact CRIG BD-unit:
Dr. Cristina Pintucci
CRIG project manager
cristina.pintucci@ugent.be
+32 9 264 9912

BD Dr. Daisy Flamez
CRIG business developer Omics platforms, diagnostics and RNA abled therapies   
daisy.flamez@ugent.be
+32 477 44 71 10

BD Dr. Dominic De Groote
CRIG business developer drug discovery and drug development
Dominic.degroote@ugent.be
+32 478 56 87 29

BD Dr. An Van Den Bulcke
CRIG business developer ChemTech technologies for life sciences
An.vandenbulcke@ugent.be
+32 474 81 23 81

 

Check out the pictures!

Via this link

 

CollageIndustrialEvent